ONE Bio Corp.
ONBI
$0.02
$0.029,900.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 0.26% | 5.20% | 8.22% | 11.16% | 224.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.26% | 5.20% | 8.22% | 11.16% | 224.81% |
| Cost of Revenue | -8.27% | -6.22% | -10.58% | 8.61% | 310.18% |
| Gross Profit | 14.68% | 23.15% | 40.51% | 15.12% | 140.29% |
| SG&A Expenses | 2.31% | 56.45% | 65.37% | 71.88% | 285.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.25% | 3.12% | 1.03% | 14.71% | 289.04% |
| Operating Income | 21.83% | 10.51% | 28.77% | 2.74% | 109.93% |
| Income Before Tax | -8.06% | 11.15% | 36.22% | -5.53% | 88.70% |
| Income Tax Expenses | 3.42% | 35.05% | 44.64% | -4.34% | 79.42% |
| Earnings from Continuing Operations | -12.08% | 3.17% | 32.98% | -5.99% | 92.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 70.47% | 20.85% | 82.16% | 144.55% | 44.86% |
| Net Income | -8.66% | 3.67% | 46.61% | 2.85% | 124.98% |
| EBIT | 21.83% | 10.51% | 28.77% | 2.74% | 109.93% |
| EBITDA | 25.23% | 11.81% | 29.78% | 1.52% | 114.47% |
| EPS Basic | -26.34% | -11.17% | 27.30% | -0.67% | 77.33% |
| Normalized Basic EPS | 1.16% | -4.02% | 32.58% | 1.21% | 79.27% |
| EPS Diluted | -24.14% | -2.94% | 41.67% | -3.74% | 70.59% |
| Normalized Diluted EPS | 0.98% | 4.87% | 43.17% | -0.94% | 72.98% |
| Average Basic Shares Outstanding | 24.00% | 16.68% | 15.18% | 3.55% | 26.87% |
| Average Diluted Shares Outstanding | 24.26% | 6.78% | 6.69% | 5.81% | 31.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |